下肢静脈瘤治療の市場規模、シェア、成長分析、タイプ別、製品別、最終用途別、地域別 - 産業予測、2025年～2032年

下肢静脈瘤治療の世界市場規模は2022年に13億米ドルと評価され、2023年の13億9,000万米ドルから2031年までには23億3,000万米ドルに成長し、予測期間（2024年～2031年）のCAGRは6.7%で成長する見通しです。

世界の下肢静脈瘤治療市場は、高齢化、座りがちなライフスタイル、肥満、遺伝などの要因に影響されるこの一般的な疾患の有病率の増加により、力強い成長を遂げています。効果的な治療オプションに対する需要は、特に静脈内レーザー焼灼術、硬化療法、ラジオ波焼灼術のような低侵襲性手技、すなわち痛みの軽減、回復時間の短縮、傷跡の軽減といった利点を提供する様々な治療法によって満たされています。技術の進歩は治療効果と患者の満足度を高め、超音波ガイド下泡沫硬化療法などの革新的な技術が人気を集めています。しかし、償還の問題や高額な治療費などの課題も残されており、これがアクセシビリティを制限する可能性もあります。さらに、競合情勢は激化しており、規制状況を乗り越えながら継続的な研究開発が必要となっています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主要な市場の考察

• 主要な成功要因
• 競合の程度
• 主要な投資機会
• 市場エコシステム
• 市場の魅力指数（2023年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析

世界の下肢静脈瘤治療の市場規模：タイプ別・CAGR（2024年～2031年）

• 市場概要
• 静脈内アブレーション
  • 静脈内レーザー治療
  • 高周波アブレーション
• 注射硬化療法
• 外科的結紮術・ストリッピング術

世界の下肢静脈瘤治療の市場規模：製品別・CAGR（2024年～2031年）

• 市場概要
• アブレーションデバイス
• 高周波アブレーション装置
• レーザーアブレーション装置
• 静脈閉鎖製品

世界の下肢静脈瘤治療の市場規模：最終用途別・CAGR（2024年～2031年）

• 市場概要
• 病院
• 外来手術センター
• 専門クリニック

世界の下肢静脈瘤治療の市場規模・CAGR（2024年～2031年）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2023年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2023年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2021年～2023年）

主要企業プロファイル

• Medtronic plc（Ireland）
• AngioDynamics, Inc.（USA）
• Teleflex Incorporated（USA）
• Boston Scientific Corporation（USA）
• Lumenis Ltd.（Israel）
• Quanta System S.p.A.（Italy）
• Biolitec AG（Austria）
• Dornier MedTech GmbH（Germany）
• Sciton, Inc.（USA）
• Fotona d.o.o.（Slovenia）
• Viatris Inc.（USA）
• Merz Aesthetics（USA）
• SIGVARIS Group（Switzerland）
• Essity Aktiebolag（publ）（Sweden）
• F Care Systems NV（Belgium）
• VVT Medical（Israel）
• Alma Lasers（Israel）
• Energist Group（UK）.
• Eufoton s.r.l.（Italy）
• WONTECH Co., Ltd.（South Korea）

結論と提言

Global Varicose Veins Treatment Market size was valued at USD 1.3 billion in 2022 and is poised to grow from USD 1.39 billion in 2023 to USD 2.33 billion by 2031, growing at a CAGR of 6.7% during the forecast period (2024-2031).

The global varicose veins treatment market is experiencing robust growth, driven by the increasing prevalence of this common condition influenced by factors such as aging populations, sedentary lifestyles, obesity, and genetics. The demand for effective treatment options is being met by a range of modalities, particularly minimally invasive procedures like endovenous laser ablation, sclerotherapy, and radiofrequency ablation, which offer benefits like reduced pain, shorter recovery times, and less scarring. Technological advancements enhance treatment effectiveness and patient satisfaction, with innovative techniques such as ultrasound-guided foam sclerotherapy gaining traction. However, challenges remain, including reimbursement issues and high treatment costs, which may limit accessibility. Additionally, the competitive landscape is intensifying, necessitating ongoing research and development while navigating regulatory hurdles.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Varicose Veins Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Varicose Veins Treatment Market Segments Analysis

Global Varicose Veins Treatment Market is segmented by type, products, end use and region. Based on type, the market is segmented into endovenous ablation, injection sclerotherapy and surgical ligation & stripping. Based on products, the market is segmented into ablation devices, radiofrequency ablation devices, laser ablation devices and venous closure products. Based on end use, the market is segmented into hospitals, ambulatory surgical centers and specialty clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Varicose Veins Treatment Market

The expansion of the Global Varicose Veins Treatment market can be attributed to the heightened awareness and education surrounding varicose veins and the diverse treatment options available. Various public awareness campaigns, coupled with patient education initiatives and the dissemination of information through multiple platforms, have played a pivotal role in motivating individuals experiencing varicose veins to pursue suitable treatment solutions. This increased understanding of the condition has helped to eliminate stigma and misinformation, ultimately fostering a more proactive approach among patients in seeking effective care and management for their venous health issues.

Restraints in the Global Varicose Veins Treatment Market

The global varicose veins treatment market faces significant challenges due to regulatory requirements and the product approval processes that manufacturers must navigate. These stringent regulations can vary widely across different countries, creating a complex landscape that demands time and financial resources. As a result, obtaining the necessary approvals can delay the launch of new treatments and innovations, ultimately impacting the market's growth and the availability of advanced therapeutic options for patients. This regulatory burden can hinder manufacturers' ability to adapt and respond to emerging trends and advancements in varicose vein treatment strategies.

Market Trends of the Global Varicose Veins Treatment Market

The Global Varicose Veins Treatment market is increasingly witnessing a trend towards combination therapies as healthcare providers seek to enhance treatment efficacy and patient satisfaction. By integrating multiple modalities, such as endovenous ablation with sclerotherapy, practitioners can effectively address various facets of venous disease, improving overall outcomes. This approach acknowledges the complexities of varicose veins, leading to more tailored treatment plans and fostering patient confidence in their care. As awareness of varicose vein complications grows and patients demand more personalized treatment options, the market is expected to expand, driving innovation and collaborations among leading medical technology companies and healthcare providers.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Varicose Veins Treatment Market Size by Type & CAGR (2024-2031)

• Market Overview
• Endovenous Ablation
  • Endovenous Laser Therapy
  • Radiofrequency Ablation
• Injection Sclerotherapy
• Surgical Ligation & Stripping

Global Varicose Veins Treatment Market Size by Products & CAGR (2024-2031)

• Market Overview
• Ablation Devices
• Radiofrequency Ablation Devices
• Laser Ablation Devices
• Venous Closure Products

Global Varicose Veins Treatment Market Size by End Use & CAGR (2024-2031)

• Market Overview
• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics

Global Varicose Veins Treatment Market Size & CAGR (2024-2031)

• North America (Type, Products, End Use)
  • US
  • Canada
• Europe (Type, Products, End Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Products, End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Products, End Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Products, End Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AngioDynamics, Inc. (USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teleflex Incorporated (USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lumenis Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quanta System S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biolitec AG (Austria)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dornier MedTech GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sciton, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fotona d.o.o. (Slovenia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Viatris Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merz Aesthetics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SIGVARIS Group (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Essity Aktiebolag (publ) (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F Care Systems NV (Belgium)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• VVT Medical (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alma Lasers (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Energist Group (UK).
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eufoton s.r.l. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WONTECH Co., Ltd. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations